Then, we analyzed the clinical significance of the ZNF667-AS1 expression, finding that the high ZNF667-AS1 expression was associated with the KPS score and advanced WHO grade, suggesting it that acted as a tumor promotor in clinical progression of glioma. This evidence concerns the gene ZNF667 and central nervous system cancer.